SMT201500160B - Nuovi derivati isochinolinici 6,7-disostituiti e loro uso - Google Patents

Nuovi derivati isochinolinici 6,7-disostituiti e loro uso

Info

Publication number
SMT201500160B
SMT201500160B SM201500160T SM201500160T SMT201500160B SM T201500160 B SMT201500160 B SM T201500160B SM 201500160 T SM201500160 T SM 201500160T SM 201500160 T SM201500160 T SM 201500160T SM T201500160 B SMT201500160 B SM T201500160B
Authority
SM
San Marino
Prior art keywords
disubstituted
isoquinoline derivatives
new isoquinoline
new
derivatives
Prior art date
Application number
SM201500160T
Other languages
English (en)
Italian (it)
Inventor
Matti Ekholm
Ville Takio
Original Assignee
Montisera Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montisera Ltd filed Critical Montisera Ltd
Publication of SMT201500160B publication Critical patent/SMT201500160B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201500160T 2010-08-11 2015-07-03 Nuovi derivati isochinolinici 6,7-disostituiti e loro uso SMT201500160B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10397511A EP2420237A1 (en) 2010-08-11 2010-08-11 Fluorinated derivatives of endogenous isoquinolines for use in the treatment of diseases mediated through endogenous isoquinoline pathways
PCT/FI2011/050707 WO2012020170A1 (en) 2010-08-11 2011-08-10 Novel 6,7-disubstituted-isoquinoline derivatives and their use
EP11770473.4A EP2603217B1 (en) 2010-08-11 2011-08-10 Novel 6,7-disubstituted-isoquinoline derivatives and their use

Publications (1)

Publication Number Publication Date
SMT201500160B true SMT201500160B (it) 2015-09-07

Family

ID=43827823

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500160T SMT201500160B (it) 2010-08-11 2015-07-03 Nuovi derivati isochinolinici 6,7-disostituiti e loro uso

Country Status (16)

Country Link
US (1) US8815898B2 (hr)
EP (2) EP2420237A1 (hr)
CN (1) CN103179971A (hr)
CA (1) CA2808016C (hr)
CY (1) CY1116588T1 (hr)
DK (1) DK2603217T3 (hr)
ES (1) ES2541401T3 (hr)
HR (1) HRP20150668T1 (hr)
HU (1) HUE026482T2 (hr)
PL (1) PL2603217T3 (hr)
PT (1) PT2603217E (hr)
RS (1) RS54081B1 (hr)
RU (1) RU2636938C2 (hr)
SI (1) SI2603217T1 (hr)
SM (1) SMT201500160B (hr)
WO (1) WO2012020170A1 (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105461626B (zh) * 2015-12-17 2018-05-08 浙江工业大学 芳环或稠杂环联3,4-二氢异喹啉类共轭结构化合物及其应用
CN105585527B (zh) * 2015-12-17 2018-06-26 浙江工业大学 2-(3,4-二氢异喹啉-1(2h)-亚基)乙腈类化合物及其应用
FI130627B (en) 2021-03-31 2023-12-18 Equinorm Ltd NEW HETEROCYCLIC COMPOUNDS AND THEIR USE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2716548B2 (ja) * 1989-11-01 1998-02-18 雅昭 廣部 パーキンソニズム予防・治療剤
DE9017900U1 (de) 1990-12-22 1993-01-28 Boehringer Ingelheim Kg, 55218 Ingelheim 3,4-Dihydro-1-benzyl-6,7-dimethoxy-α- [di-2-(2,3,4-trimethoxyphenyl)ethyl] aminocarbonyl-isochinolin
US5491148A (en) 1991-04-26 1996-02-13 Syntex (U.S.A.) Inc. Isoquinolinone and dihydroisoquinolinone 5-HT3 receptor antagonists
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
ES2230618T3 (es) 1996-09-27 2005-05-01 Aventis Pharmaceuticals Inc. Reaccion de pictet-spengler para la sintesis de tetrahidroisoquinolinas y compuestos heterociclicos relacionados.
KR100878855B1 (ko) * 1999-11-03 2009-01-15 에이엠알 테크놀로지, 인크. 4-페닐-치환 테트라히드로이소퀴놀린, 및 노르에피네프린과 도파민과 세로토닌의 재흡수를 차단하기 위한 이의 용도
WO2006035280A1 (en) 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases
US20060111393A1 (en) * 2004-11-22 2006-05-25 Molino Bruce F 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
EP2090576A1 (en) * 2008-02-01 2009-08-19 Merz Pharma GmbH & Co.KGaA 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators

Also Published As

Publication number Publication date
RU2013110377A (ru) 2014-09-20
PL2603217T3 (pl) 2015-09-30
RU2636938C2 (ru) 2017-11-29
EP2603217A1 (en) 2013-06-19
EP2420237A1 (en) 2012-02-22
HRP20150668T1 (hr) 2015-09-11
CN103179971A (zh) 2013-06-26
HUE026482T2 (en) 2016-06-28
SI2603217T1 (sl) 2015-08-31
PT2603217E (pt) 2015-08-26
CA2808016A1 (en) 2012-02-16
ES2541401T3 (es) 2015-07-20
CA2808016C (en) 2018-10-30
US8815898B2 (en) 2014-08-26
CY1116588T1 (el) 2017-03-15
RS54081B1 (en) 2015-10-30
US20130137719A1 (en) 2013-05-30
DK2603217T3 (en) 2015-07-13
EP2603217B1 (en) 2015-04-08
WO2012020170A1 (en) 2012-02-16

Similar Documents

Publication Publication Date Title
SMT201600226B (it) Alcune amminopirimidine, loro composizioni e metodi per il loro uso
SMT201600157B (it) Composti di carbammoilpiridone policiclici e loro uso farmaceutico
SMT201600354B (it) Composti di beta-lattame sostituiti da ammidina, loro preparazione ed uso come agenti antibatterici
SMT201500213B (it) Alcune triazolopirazine, loro composizioni e metodi d'uso
SMT201600198B (it) Derivati di 1,2,4-triazina-4-ammina
BR112013023681A2 (pt) compostos de álcool propargílico 6,5-heterocíclico e uso dos mesmos
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
BR112013015592A2 (pt) dericados de biciclo-[3.2.1]-octilamida e usos dos mesmos
BR112012002349A2 (pt) composto,e, uso do mesmo
BR112014014763A2 (pt) novos conjugados de anticorpo-medicamento (adcs) e uso dos mesmos
CO6930362A2 (es) Compuesto heterocíclico y su uso
SMT201600223B (it) Composti eterociclici e loro uso come modulatori di tirosin chinasi di tipo iii
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112013010988A2 (pt) composição fluída e uso
BRPI1010024A2 (pt) derivados de aminopirrolidinona e uso dos mesmos
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
BRPI0823082A2 (pt) Uso derivados de sesquiterpeno
CO6781486A2 (es) Compuestos y su uso
SMT201400185B (it) Derivati di 3,4,4A, 10B-tetraidro-1H-tiopirano-[4,3-C]isochinolina
BRPI1011036A2 (pt) uso
CR20140362A (es) Fenilimidazopirazoles sustituidos y su uso
SMT201400157B (it) Derivati di 2-piridin-2-il-pirazol-3(2H)-one, loropreparazione e loro uso terapeutico
BR112014025416A2 (pt) AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS.
IL238452A0 (en) History of new modified 4,1-dithienes and their use as fungicides
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”